Meet the 2020 Laureates: Richard J. Santen, MD

  • By Robert M. Carey, MD, MACP, dean, emeritus, and professor of medicine, University of Virginia School of Medicine, Charlottesville, Va.; and Laurence M. Demers, DABCC, FACB, distinguished professor emeritus, Pathology and Medicine, The M. S. Hershey Medical Center, The Pennsylvania State University, Hershey, Pa.
  • Mar 2020
santen

Richard J. Santen, MD

Fred Conrad Koch Lifetime Achievement Award

Richard J. Santen, MD, is professor of medicine at the University of Virginia and a former president of the Endocrine Society. His impressive clinical and research career has focused on both prostate and breast cancer. His pioneering work led to the development of first, second, and third generation aromatase inhibitors for the treatment of hormone-dependent breast cancer. His laboratory has continued with seminal publications on the study of the mechanisms relating estrogens to breast cancer and the biology and natural history of endocrine-dependent forms of breast cancer.

He has published over 400 manuscripts and chapters, predominantly related to the role that estrogen plays in breast cancer development. His expertise in estrogens led to a strong clinical interest in the treatment of menopause and to his selection by the Endocrine Society to write a definitive Scientific Statement on this topic. He enlisted 34 internationally diverse, expert clinicians to write this treatise.

For his work in the development of aromatase inhibitors, now standard of care for hormone dependent breast cancer, he received the Susan Komen Foundation Brinker International Award for breast cancer clinical research in 1993. Other awards include the American Association of Clinical Chemistry Distinguished Science Award, the Robert H. Williams Distinguished Leadership Award of the Endocrine Society, and the William L. McGuire Memorial Lectureship Award for breast cancer.

During his illustrious career, Dr. Santen has been a major contributor to the Endocrine Society, serving as chair of the Finance Committee, spearheading a financial plan to secure the long-term stability of the Endocrine Society, initiating the International Scholars program of the Endocrine Society, and, as president of the Endocrine Society, leading an initiative to support the next generation of endocrinologists. Recognized as a leading clinical endocrinologist, Santen’s achievements have spanned the clinical, research, teaching, and administrative spectrum.

You may also like

  • Endocrine Society Endorses Bipartisan Bill to Address Insulin Affordability 

    INSULIN Act would expand insulin co-pay cap to commercial market and encourage competition. The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA).   This historic legislation would cap out-of-pocket insulin costs at $35 per month for people on private insurance, protecting access to this life-saving medication for millions of people with diabetes. The legislation also would create a program to…

  • In Memoriam: Martin Savage 1941-2026

    By Richard Ross, Emeritus Professor of Endocrinology, University of Sheffield, UK, and Helen Storr, Professor of Pediatric Endocrinology, Queen Mary University London

    Martin O. Savage, Emeritus Professor of Pediatric Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, passed away on February 24, 2026. Martin Savage was a kind, generous, quietly spoken man, an inspirational pediatrician and an internationally renowned clinician scientist. He was passionate about teaching…

Find more in